Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort Study. 2017

Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

BACKGROUND Cardiothoracic ratio by chest radiography is commonly used to assess volume status. Little is known about the relationships between cardiothoracic ratio and the incidence of clinical outcomes in patients undergoing hemodialysis (HD). METHODS Prospective cohort study. METHODS 3,436 participants in the Q-Cohort Study 18 years or older who underwent maintenance HD in Japan. METHODS Cardiothoracic ratio. METHODS All-cause mortality and cardiovascular disease (CVD) events. RESULTS During a 4-year follow-up period, 564 (16.4%) patients died of any cause and 590 (17.2%) developed CVD events. From baseline cardiothoracic ratios, participants were categorized into sex-specific quartiles because cardiothoracic ratio distribution differed by sex. The 4-year event-free survival rate, in terms of all-cause mortality and CVD events, was significantly lower with higher cardiothoracic ratios. Compared to the lowest cardiothoracic ratio (quartile 1), multivariable-adjusted HRs for all-cause mortality were 0.89 (95% CI, 0.66-1.20), 1.41 (1.08-1.86), and 1.52 (1.17-2.00) in patients from quartiles 2, 3, and 4, respectively. Similarly, in comparison to quartile 1, multivariable-adjusted HRs for CVD events were 1.00 (95% CI, 0.77-1.31), 1.18 (0.92-1.53), and 1.37 (1.07-1.76) in patients from quartiles 2, 3, and 4, respectively. Furthermore, the combination of higher cardiothoracic ratio and normohypotension (systolic blood pressure < 140mmHg and diastolic blood pressure < 90mmHg) was associated with higher risk for CVD events. CONCLUSIONS Single measurement of all variables, potentially less-heterogeneous patient population, and limited ascertainment of cardiac parameters and the outcomes. CONCLUSIONS Higher cardiothoracic ratio is associated with higher risk for both all-cause mortality and CVD events in patients undergoing HD.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts

Related Publications

Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
October 2017, Clinical and experimental nephrology,
Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
October 2017, Clinical and experimental nephrology,
Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
October 2017, Clinical and experimental nephrology,
Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
April 2017, Journal of atherosclerosis and thrombosis,
Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
January 2016, Renal failure,
Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
January 2018, Hemodialysis international. International Symposium on Home Hemodialysis,
Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
January 2017, American journal of nephrology,
Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
January 2023, International journal of environmental research and public health,
Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
January 2017, European journal of endocrinology,
Ryusuke Yotsueda, and Masatomo Taniguchi, and Shigeru Tanaka, and Masahiro Eriguchi, and Kiichiro Fujisaki, and Kumiko Torisu, and Kosuke Masutani, and Hideki Hirakata, and Takanari Kitazono, and Kazuhiko Tsuruya
January 2023, Renal failure,
Copied contents to your clipboard!